About Xencor, Inc.
Xencor, Inc.- Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDA Technology Product Sheet Caltech spin-off developing proteomic technologies to accelerate drug discovery.
